WSES · 2017

Adhesive Small Bowel Obstruction — Conservative vs. Operative Decision

Source: Bologna guidelines for diagnosis and management of adhesive small bowel obstruction (ASBO): 2017 update, World Journal of Emergency Surgery; supplemented by the WSES Cesena consensus statement on laparoscopic-first approach to general surgery emergencies,

Guideline: Strong Guideline: Conditional Guideline: Not recommended ClinicoQ pathway suggestion (not from the cited guideline)

Diagnosis

Diagnostic criteria Suspected based on a history of abdominal surgery (adhesions), colicky abdominal pain, distension, vomiting, and absence of flatus/bowel movements. CT scan is the preferred initial imaging to confirm obstruction, assess transition point, and look for signs of strangulation.

⚠ Alarm features (investigate before diagnosing)

Signs of peritonitis (guarding, rebound tenderness, rigidity)
Signs of strangulation or bowel ischemia (persistent severe pain, fever, tachycardia, leukocytosis, or CT findings: free fluid, mesenteric edema, small-bowel feces sign, devascularization)
History of persistent vomiting despite decompression

Initial workup

Test	When to order
CT scan with water-soluble oral contrast	Preferred initial diagnostic workup in all suspected ASBO — assesses obstruction, transition point, and signs of strangulation.
Laboratory tests (CBC, lactate, electrolytes, BUN/creatinine)	In all patients at initial evaluation, to assess nutritional/metabolic status and support strangulation risk assessment.
Follow-up abdominal X-ray at 24 hours (after water-soluble contrast)	In patients managed non-operatively, to assess whether contrast has reached the colon (predicts resolution).

Decision Points

❓ Are there signs of peritonitis, strangulation, or bowel ischemia?

Yes — any emergency sign present → Emergency surgery

No emergency signs → Non-operative management (NOM)

❓ Has water-soluble contrast reached the colon on X-ray within 24 hours of administration?

Yes — contrast reached the colon → Continue NOM — resolution predicted

No — contrast has not reached the colon → Surgery after failed NOM

❓ Has NOM been continued for 72 hours without resolution?

No — still within the 72-hour window → Continue NOM — resolution predicted

Yes — 72 hours reached without resolution → Surgery after failed NOM

Treatment

Non-operative management (NOM)

1 Bowel rest, nasogastric tube decompression, IV fluids/electrolyte correction Strong (Guideline recommendation) — treatment of choice absent emergency signs

Dose: NGT decompression; long trilumen naso-intestinal tubes are more efficacious than NGT alone but require endoscopic placement
Duration: Trial of up to 72 hours
Evidence level: High
Avoid if: Signs of peritonitis, strangulation, or bowel ischemia
If no response ClinicoQ pathway: Administer water-soluble contrast medium (WSCM), either at admission or after an initial 48-hour NOM trial, for diagnostic and therapeutic purposes

Continue NOM — resolution predicted

1 Continue conservative management; monitor for resolution Strong (Guideline recommendation)

Dose: -
Duration: Contrast reaching the colon within 24h strongly predicts resolution without surgery
Evidence level: High
Avoid if: New emergency signs develop
If no response: -

Surgery after failed NOM

1 Surgical adhesiolysis (open or laparoscopic) Strong (Guideline recommendation) — recommended once the 72-hour NOM window has passed without resolution

Dose: - surgical procedure
Duration: After 72 hours of unsuccessful NOM
Evidence level: Moderate
Avoid if: -
If no response: -

2 Laparoscopic adhesiolysis (in stable patients requiring surgical treatment, with appropriate expertise) 2017 Bologna guideline (Conditional): preferably for first-episode SBO with anticipated single-band obstruction. 2023 WSES Cesena consensus statement (a separate position paper, not the same rigor as a full clinical practice guideline) broadens this: in stable patients with ASBO requiring surgical treatment and no contraindication to pneumoperitoneum, laparoscopic adhesiolysis is considered safe and should be recommended, not limited to first-episode/single-band cases

Dose: - surgical procedure; open (Hasson) access technique preferred, typically via left upper quadrant/flank
Duration: -
Evidence level: Low-Moderate (2017 Bologna guideline); the 2023 WSES Cesena consensus statement broadens this
Avoid if: Multiple prior surgeries with extensive matted adhesions, or signs suggesting a complex obstruction; hemodynamic instability or contraindication to pneumoperitoneum
If no response ClinicoQ pathway: Convert to open surgery if safe laparoscopic adhesiolysis is not feasible

Emergency surgery

1 Emergent open surgical exploration Strong (Guideline recommendation, 2017 Bologna). Note: the 2023 WSES Cesena consensus statement suggests a laparoscopic-first approach may also be considered in hemodynamically stable patients even with suspected strangulation, at centers with appropriate expertise — but open surgery remains the guideline-recommended default, especially outside expert centers

Dose: - surgical procedure; open surgery is generally preferred over laparoscopy for strangulating ASBO per the 2017 Bologna guideline
Duration: Without delay
Evidence level: Moderate
Avoid if: -
If no response: -

✕ Treatments the guideline advises against

Plain abdominal X-ray as the primary diagnostic workup tool: Guideline states plain X-rays have only limited diagnostic value in ASBO workup and are not recommended — CT scan with water-soluble contrast is the preferred initial imaging.

Extending NOM beyond 72 hours without resolution: Guideline recommends surgery once 72 hours of NOM has passed without resolution — outcomes worsen (more complications, resection, prolonged stay, death) when surgery is delayed to day 4 or later.

⚠️ Currency note: the core diagnostic and NOM-vs-surgery decision framework is based on the 2017 Bologna guideline, still the current dedicated WSES clinical practice guideline for ASBO as of September 2026. The laparoscopic adhesiolysis sections are supplemented with the 2023 WSES Cesena consensus statement, a separate position paper (not a full graded clinical practice guideline) that broadens the case for a laparoscopic-first approach in stable patients — this is labeled distinctly from the 2017 guideline's own recommendation above. This is an educational summary of current international clinical practice guidelines and does not replace individualized clinical judgment. Final treatment decisions remain the responsibility of the treating physician.